269 studies found for:    "Adrenal Gland Diseases" [DISEASE]
Show Display Options
Rank Status Study
21 Recruiting Optimizing Diagnosis Of Primary Aldosteronism
Condition: Primary Aldosteronism
Intervention:
22 Not yet recruiting Sleep Apnea Diagnosis Using a Novel Pace-maker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction (SAPAAD)
Conditions: Sleep Apnea;   Arrhythmias, Cardiac;   Cardiac Diastolic Function;   Hyperaldosteronism
Interventions: Other: pacemaker diagnostic algorithm;   Other: Attended cardiorespiratory sleep study
23 Not yet recruiting Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors
Conditions: Adrenal Cortex Neoplasms;   Adrenal Cortex Diseases
Intervention:
24 Recruiting Extension Study for Patients Entered Into Study Infacort 003
Condition: Adrenal Insufficiency
Intervention: Drug: Infacort®
25 Completed Treatment of Adrenal Insufficiency in Children
Condition: Adrenal Insufficiency
Intervention: Drug: Infacort®
26 Recruiting Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Conditions: Metastatic Carcinoma in the Adrenal Cortex;   Recurrent Adrenal Cortex Carcinoma;   Stage III Adrenal Cortex Carcinoma;   Stage IV Adrenal Cortex Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nivolumab
27 Recruiting Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Interventions: Drug: Chronocort®;   Drug: standard glucocorticoid therapy
28 Not yet recruiting Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Condition: Hurler Syndrome, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy, Krabbe, Cerebral Adrenoleukodystrophy
Intervention: Drug: Umbilical cord blood transplantation with HSC835
29 Enrolling by invitation Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
Conditions: Cerebral Adrenoleukodystrophy (CALD);   Adrenoleukodystrophy (ALD);   X-Linked Adrenoleukodystrophy (X-ALD)
Intervention: Other: Safety and efficacy assessments
30 Recruiting National Education Programme for Patients With Chronic Adrenal Insufficiency
Condition: Adrenal Insufficiency
Intervention: Other: Education
31 Not yet recruiting Vaginal Prednisone Administration for Prevention of Adrenal Crisis
Condition: Adrenal Insufficiency
Intervention: Drug: 100mg prednisone suppository
32 Recruiting Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Pembrolizumab
33 Recruiting Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card
Condition: Adrenal Gland Neoplasms
Intervention: Biological: omics identity card
34 Enrolling by invitation Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Other: No intervention
35 Recruiting Saliva Cortisol Measurement as a Screening Test for Suspicious Cushings Syndrome in Children.
Condition: Cushings Syndrome
Intervention: Other: Children refered to the obesity clinic
36 Recruiting Renal Sympathetic Denervation From The Adventitia on Hypertension
Condition: Primary Aldosteronism Due to Aldosterone Producing Adenoma
Intervention: Device: Renal Sympathetic Denervation
37 Not yet recruiting Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
Condition: Cushing's Syndrome Cardiomyopathy
Intervention: Drug: Tadalafil
38 Recruiting A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy
Condition: X-linked Adrenoleukodystrophy
Intervention: Dietary Supplement: vitamin D3
39 Not yet recruiting Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Abiraterone acetate
40 Recruiting Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
Condition: Pituitary Adenoma
Intervention: Device: continuous glucose monitoring

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years